JMIR Publications

ABSTRACT

Therapeutic and interventional digital health solutions often use machine learning (ML) models to make predictions of repeated adverse health outcomes. For example, models may be used to analyze patient data and identify patterns that can anticipate the likelihood of disease exacerbations, enabling timely interventions and personalized treatment plans to improve overall health outcomes. However, many digital health applications require the prediction of highly heterogeneous health events. The cross-subject variability of these events makes traditional ML approaches, where a single generalized model is trained to classify a particular condition, infeasible without overfitting to the training set. A natural solution is to train a separate model for each individual or subgroup, essentially overfitting the model to the unique characteristics of the individual without negatively overfitting in terms of the desired prediction task. Unfortunately, such an approach requires extensive data labels from each individual, a reality that has rendered personalized ML infeasible for precision healthcare. The recent popularization of self-supervised learning, however, provides a solution to this issue: by pre-training deep learning models on the vast array of unlabeled data streams arising from patient generated health data, personalized models can be fine-tuned to predict the health outcome of interest with much fewer labels, making personalization of deep learning models much more achievable from a practical perspective. This perspective describes the current state-of-the-art in both self-supervised learning and ML personalization for healthcare as well as growing efforts to combine these two ideas. Personalized self-supervised learning is likely to enable a wide array of digital therapeutics in the coming years.